Goldman Sachs Group set a GBX 7,200 ($94.08) price target on Reckitt Benckiser Group (LON:RB) in a report issued on Tuesday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.
Several other brokerages have also issued reports on RB. Kepler Capital Markets raised Reckitt Benckiser Group to a buy rating and raised their price objective for the stock from GBX 6,300 ($82.32) to GBX 6,900 ($90.16) in a report on Tuesday, May 7th. Bryan, Garnier & Co reaffirmed a neutral rating and set a GBX 6,870 ($89.77) price objective (up previously from GBX 6,800 ($88.85)) on shares of Reckitt Benckiser Group in a report on Tuesday. Barclays raised their price objective on Reckitt Benckiser Group from GBX 7,500 ($98.00) to GBX 8,100 ($105.84) and gave the stock an overweight rating in a report on Tuesday, July 9th. HSBC set a GBX 7,900 ($103.23) price objective on Reckitt Benckiser Group and gave the stock a buy rating in a report on Thursday, July 18th. Finally, Liberum Capital reaffirmed a buy rating on shares of Reckitt Benckiser Group in a report on Tuesday. Four equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of GBX 7,153.89 ($93.48).
Reckitt Benckiser Group stock opened at GBX 6,152 ($80.39) on Tuesday. Reckitt Benckiser Group has a 1-year low of GBX 5,559 ($72.64) and a 1-year high of GBX 7,174 ($93.74). The company has a debt-to-equity ratio of 80.49, a quick ratio of 0.47 and a current ratio of 0.65. The firm has a market capitalization of $43.62 billion and a PE ratio of 20.18. The company has a fifty day simple moving average of GBX 6,430.86.
In related news, insider Christopher Sinclair purchased 1,076 shares of the stock in a transaction that occurred on Thursday, May 23rd. The shares were purchased at an average price of GBX 6,375 ($83.30) per share, with a total value of £68,595 ($89,631.52). Also, insider Andrew R. J. Bonfield purchased 146 shares of the stock in a transaction that occurred on Tuesday, May 21st. The shares were bought at an average cost of GBX 6,290 ($82.19) per share, for a total transaction of £9,183.40 ($11,999.74).
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Further Reading: How do buyers and sellers choose a strike price?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.